Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-20 Sale |
2024-09-24 7:41 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
16,047 | $102.35 | $1,642,359 | 93,608 (Direct) |
View |
| 2024-08-22 Sale |
2024-08-26 8:15 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
18,858 | $105.34 | $1,986,420 | 49,510 (Direct) |
View |
| 2024-08-09 Sale |
2024-08-13 5:21 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
18,245 | $98.5 | $1,797,133 | 68,368 (Direct) |
View |
| 2024-05-13 Sale |
2024-05-15 7:34 pm |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating |
17,598 | $84.99 | $1,495,740 | 86,263 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award(A) |
2025-02-10 5:21 pm |
N/A 2035-02-05 |
PALVELLA THERAPEUTICS INC. | PVLA | Korenberg Matthew E CFO and Treasurer |
128,932 | $0 | 128,932 (Direct) |
View |
| 2024-12-13 Option Award |
2024-12-17 8:43 pm |
N/A 2034-12-13 |
PALVELLA THERAPEUTICS INC. | PVLA | Korenberg Matthew E CFO, Treasurer |
167,100 | $0 | 167,100 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 7:41 pm |
N/A 2026-02-11 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
14,754 | $0 | 93,608 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
9,377 | $52.84 | 93,608 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
5,377 | $49.99 | 93,608 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,340 | $60.94 | 114,348 (Direct) |
View |
| 2024-09-16 Tax Withholding |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,214 | $105 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
914 | $55.75 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A 2026-02-11 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
5,774 | $0 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
671 | $49.99 | 114,348 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 7:55 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
849 | $58.49 | 114,348 (Direct) |
View |
| 2024-08-19 Option Award |
2024-08-21 7:52 pm |
N/A N/A |
LIFECORE BIOMEDICAL INC. | LFCR | Korenberg Matthew E Director |
24,554 | $0 | 24,554 (Direct) |
View |
Ownership |
2024-08-21 6:27 pm |
N/A N/A |
LIFECORE BIOMEDICAL INC. | LFCR | Korenberg Matthew E Director |
0 | $0 | 0 (Direct) |
View |
| 2024-06-28 Other |
2024-07-02 7:45 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & Chief Operating |
350 | $60.71 | 86,963 (Direct) |
View |
| 2024-02-27 Option Award |
2024-02-29 6:50 pm |
N/A 2034-02-27 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
72,960 | $0 | 162,405 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 8:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
4,778 | $74.65 | 89,445 (Direct) |
View |
| 2024-01-02 Tax Withholding |
2024-01-04 4:07 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
2,917 | $72.31 | 94,223 (Direct) |
View |
| 2023-12-05 Tax Withholding |
2023-12-06 3:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
1,984 | $59.61 | 97,140 (Direct) |
View |
| 2023-06-30 Other |
2023-07-10 6:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E PRESIDENT & CHIEF OPERATING |
376 | $56.78 | 99,500 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:52 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
33,697 | $0 | 123,376 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
2,890 | $72.98 | 89,679 (Direct) |
View |
| 2022-12-28 Tax Withholding |
2022-12-30 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,859 | $66.29 | 92,569 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:34 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
25,967 | $0 | 25,967 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:17 pm |
N/A 2032-12-13 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
44,000 | $0 | 126,428 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,593 | $72.9 | 82,428 (Direct) |
View |
| 2022-11-01 Option Award |
2022-11-03 9:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
27,714 | $0 | 86,021 (Direct) |
View |
| 2022-07-11 Option Award |
2022-08-04 4:16 pm |
N/A 2032-07-11 |
Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-30 Other |
2022-07-06 8:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
164 | $75.84 | 52,696 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 5:54 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
8,062 | $0 | 52,368 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-09 8:10 pm |
N/A 2032-05-05 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
30,189 | $0 | 30,189 (Direct) |
View |
| 2022-02-15 Tax Withholding |
2022-02-16 8:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
3,407 | $123.68 | 44,306 (Direct) |
View |
| 2022-01-26 Tax Withholding |
2022-01-28 8:43 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
3,628 | $113.68 | 47,713 (Direct) |
View |
| 2022-01-26 Option Award |
2022-01-28 8:43 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
11,651 | $0 | 47,713 (Direct) |
View |
| 2021-06-30 Other |
2021-07-02 5:13 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
247 | $85.91 | 39,937 (Direct) |
View |
| 2021-02-15 Tax Withholding |
2021-02-18 6:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
2,309 | $172.46 | 39,443 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 5:02 pm |
N/A 2031-02-03 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
22,410 | $0 | 53,343 (Direct) |
View |
| 2021-01-25 Option Award |
2021-01-27 7:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
7,108 | $0 | 30,933 (Direct) |
View |
| 2021-01-25 Tax Withholding |
2021-01-27 7:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
2,111 | $156.01 | 30,933 (Direct) |
View |
| 2020-06-30 Other |
2020-07-01 8:05 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
238 | $89.03 | 26,174 (Direct) |
View |
| 2020-06-06 Option Award |
2020-06-08 9:22 pm |
N/A 2030-06-06 |
Qualigen Therapeutics Inc. | QLGN | Korenberg Matthew E Director |
50,000 | $0 | 50,000 (Direct) |
View |